156 related articles for article (PubMed ID: 2264338)
41. [Clinical evaluation of radioimmunoscintigraphy using a I-131 anti CEA and CA 19-9 monoclonal antibodies cocktail (IMACIS-1)].
Takahashi T; Tsujino D; Kato Y; Wada Y; Someya K; Itagaki K; Imanishi Y; Ishikawa T; Sakaki T; Sasaki Y
Gan No Rinsho; 1989 Jun; 35(7):828-33. PubMed ID: 2739074
[TBL] [Abstract][Full Text] [Related]
42. Immunoscintigraphy of colorectal carcinomas and recurrences with a technetium-99m-labeled monoclonal anti-CEA-antibody (MAB XBW 431/26).
Lind P
J Nucl Med; 1990 Apr; 31(4):535-6. PubMed ID: 2157833
[No Abstract] [Full Text] [Related]
43. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma].
Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M
Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391
[TBL] [Abstract][Full Text] [Related]
44. [Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies].
Bosslet K; Schwarz A; Steinstraesser A; Kuhlmann L; Seidel L; Schulz G
Wien Med Wochenschr; 1988 Jun; 138(11-12):255-7. PubMed ID: 3262953
[TBL] [Abstract][Full Text] [Related]
45. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
Yao YF; Yang Z; Li ZF; Gu J
World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
[TBL] [Abstract][Full Text] [Related]
46. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
Bock E; Becker W; Scheele J; Wolf F
Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
[TBL] [Abstract][Full Text] [Related]
48. Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.
Obradovic V; Artiko V; Petrovic M; Lausevic Z; Stojkovic M; Sobic-Saranovic D; Petrovic N; Vlajkovic M; Krivokapic Z
Neoplasma; 2006; 53(5):444-9. PubMed ID: 17013541
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of an anti-carcinoembryonic monoclonal antibody suitable for immunoscintigraphy.
Moraes DW; Lima EN; Prado IB; Carneiro CR
Braz J Med Biol Res; 1999 Aug; 32(8):967-74. PubMed ID: 10454758
[TBL] [Abstract][Full Text] [Related]
50. Anti-CEA labelling kit BW 431/26. Results of the European multicenter trial.
Steinsträsser A; Oberhausen E
Nuklearmedizin; 1995 Dec; 34(6):232-42. PubMed ID: 8596740
[TBL] [Abstract][Full Text] [Related]
51. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans.
Sharkey RM; Goldenberg DM; Goldenberg H; Lee RE; Ballance C; Pawlyk D; Varga D; Hansen HJ
Cancer Res; 1990 May; 50(9):2823-31. PubMed ID: 2328505
[TBL] [Abstract][Full Text] [Related]
52. Radioimmunodetection of cancer of gastrointestinal tract and liver metastasis with I-131 anti-CEA and I-131 anti-CA19-9 monoclonal antibody cocktail (IMACIS-1).
Naruki Y; Urita Y; Miyachi Y; Otsuka S; Noguchi M; Kogure T; Sasaki Y
Ann Nucl Med; 1994 Aug; 8(3):163-9. PubMed ID: 7811557
[TBL] [Abstract][Full Text] [Related]
53. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer.
Kairemo KJ
Cancer Res; 1990 Feb; 50(3 Suppl):949s-954s. PubMed ID: 2297747
[TBL] [Abstract][Full Text] [Related]
54. Immunoscintigraphy with combinations of various monoclonal antibodies--studies on xenografts of human gastrointestinal carcinomas.
Horstmeier U; Klapdor R; Bahlo M; Montz R
Nuklearmedizin; 1988 Mar; 27(2):46-50. PubMed ID: 3163421
[TBL] [Abstract][Full Text] [Related]
55. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
[TBL] [Abstract][Full Text] [Related]
56. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.
Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C
Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277
[TBL] [Abstract][Full Text] [Related]
57. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
Sandrock D; Blossey HC; Steinroeder M; Munz DL
Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
[TBL] [Abstract][Full Text] [Related]
58. [Immunoscintigraphy in stomach neoplasms with anti-CEA BW 431/26 monoclonal antibodies marked with Tc 99 m].
González P; Escobar MI; Csendes A; Lillo R; Fodor M; Guzmán G; Baum RP; Massardo T; Gaínza V; Otárola S
Rev Med Chil; 1991 May; 119(5):572-6. PubMed ID: 1844299
[TBL] [Abstract][Full Text] [Related]
59. [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers].
Schlag P; Hölting T; Steinbächer M; Kretzschmar U; Georgi P
Chirurg; 1987 Sep; 58(9):594-6. PubMed ID: 3677890
[TBL] [Abstract][Full Text] [Related]
60. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.
Buchegger F; Mach JP; Pèlegrin A; Gillet M; Vogel CA; Buclin T; Ryser JE; Delaloye B; Delaloye AB
J Nucl Med; 1995 Mar; 36(3):420-9. PubMed ID: 7884504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
